Your browser doesn't support javascript.
loading
Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.
Yonesaka, Kimio; Hayashi, Hidetoshi; Nakamura, Atsushi; Sato, Yuki; Azuma, Koichi; Sakata, Shinya; Tachihara, Motoko; Ikeda, Satoshi; Yokoyama, Toshihide; Ito, Kentaro; Yano, Yukihiro; Matsumoto, Hirotaka; Daga, Haruko; Hata, Akito; Sakai, Kazuko; Chiba, Yasutaka; Nishio, Kazuto; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko.
Afiliación
  • Yonesaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan. Electronic address: yonesaka@med.kindai.ac.jp.
  • Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
  • Nakamura A; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan.
  • Sato Y; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Azuma K; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Sakata S; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Ikeda S; Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
  • Yokoyama T; Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ito K; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Yano Y; Department of Thoracic Oncology, National Hospital Organization, Osaka Toneyama Medical Center, Toyonaka, Japan.
  • Matsumoto H; Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
  • Daga H; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan.
  • Hata A; Department of Thoracic Oncology, Kobe Minimally Invasive Cancer Center, Kobe, Japan.
  • Sakai K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Chiba Y; Clinical Research Center, Kindai University Hospital, Osaka-Sayama, Japan.
  • Nishio K; Department of Genome Biology, Kindai University Faculty of Medicine, Osaka-Sayama, Japan.
  • Yamamoto N; Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
Clin Lung Cancer ; 24(6): 519-527.e4, 2023 09.
Article en En | MEDLINE | ID: mdl-37344331
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article